CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience , National Center for NanoScience and Technology , 11 BeiYiTiao , ZhongGuanCun, Beijing 100190 , China.
University of Chinese Academy of Sciences , Beijing 100049 , China.
ACS Appl Mater Interfaces. 2019 Mar 27;11(12):11112-11118. doi: 10.1021/acsami.8b21724. Epub 2019 Mar 19.
Delivery of proteins to carry out desired biological functions is a direct approach for disease treatment. However, protein therapy is still facing challenges due to low delivery efficiency, poor targeting during trafficking, insufficient therapeutic efficacy, and possible toxicity induced by carriers. Here, we present a novel delivery platform based on DNA origami nanostructure that enables tumor cell transportation of active proteins for cancer therapy. In our design, cytotoxic protein ribonuclease (RNase) A molecules are organized on the rectangular DNA origami nanosheets, which work as nanovehicles to deliver RNase A molecules into the cytoplasm and execute their cell-killing function inside the tumor cells. Cancer cell-targeting aptamers are also integrated onto the DNA origami-based nanoplatform to enhance its targeting effect. This DNA origami-protein coassembling strategy can be further developed to transport other functional proteins and therapeutic components simultaneously for synergistic effects and be adapted for integrated diagnostics and therapeutics.
将蛋白质递送到发挥所需生物功能的位置是一种治疗疾病的直接方法。然而,由于递送效率低、运输过程中靶向性差、治疗效果不足以及载体可能引起的毒性,蛋白质疗法仍然面临挑战。在这里,我们提出了一种基于 DNA 折纸纳米结构的新型递药平台,该平台能够实现活性蛋白向肿瘤细胞的运输,用于癌症治疗。在我们的设计中,细胞毒性蛋白核糖核酸酶(RNase)A 分子被组织在矩形 DNA 折纸纳米片上,充当纳米载体将 RNase A 分子递送到细胞质中,并在肿瘤细胞内发挥其杀伤细胞的功能。癌细胞靶向适体也被整合到基于 DNA 折纸的纳米平台上,以增强其靶向效果。这种 DNA 折纸-蛋白质共组装策略可以进一步发展,以同时递运其他功能蛋白和治疗成分,以实现协同作用,并适用于集成诊断和治疗。